Khalil, D. N., Smith, E. L., Brentjens, R. J. & Wolchok, J. D. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat. Rev. Clin. Oncol. 13, 273–290 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gide, T. N., Wilmott, J. S., Scolyer, R. A. & Long, G. V. Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma. Clin. Cancer Res. 24, 1260–1270 (2018).

Article  CAS  PubMed  Google Scholar 

Brahmer, J. R. et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J. Immunother. Cancer 6, 75 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Fehrenbacher, L. et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet 387, 1837–1846 (2016).

Article  CAS  PubMed  Google Scholar 

Gandhi, L. et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N. Engl. J. Med. 378, 2078–2092 (2018).

Article  CAS  PubMed  Google Scholar 

Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A. & Wargo, J. A. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 33, 570–580 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V. & Wargo, J. A. The microbiome, cancer, and cancer therapy. Nat. Med. 25, 377–388 (2019).

Article  CAS  PubMed  Google Scholar 

Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G. & Gajewski, T. F. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science 359, 1366–1370 (2018).

Article  CAS  PubMed  Google Scholar 

Garrett, W. S. Cancer and the microbiota. Science 348, 80–86 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690–703 (2022).

Article  CAS  PubMed  Google Scholar 

Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, L., Li, A., Wang, Y. & Zhang, Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal. Transduct. Target. Ther. 8, 35 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973–980 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poore, G. D. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 579, 567–574 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parhi, L. et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat. Commun. 11, 3259 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heymann, C. J. F., Bard, J. M., Heymann, M. F., Heymann, D. & Bobin-Dubigeon, C. The intratumoral microbiome: characterization methods and functional impact. Cancer Lett. 522, 63–79 (2021).

Article  CAS  PubMed  Google Scholar 

Fessler, J., Matson, V. & Gajewski, T. F. Exploring the emerging role of the microbiome in cancer immunotherapy. J. Immunother. Cancer 7, 108 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Xue, C. et al. Current understanding of the intratumoral microbiome in various tumors. Cell Rep. Med. 4, 100884 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fulbright, L. E., Ellermann, M. & Arthur, J. C. The microbiome and the hallmarks of cancer. PLoS Pathog. 13, e1006480 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Frankel, A. E. et al. Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia 19, 848–855 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178, 795–806.e12 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebbell, B. The Papyrus Ebers, The Greatest Egyptian Medical Document (Levin & Munksgaard; H. Milford; Oxford University Press, 1937).

Kang, S. R., Nguyen, D. H., Yoo, S. W. & Min, J. J. Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Adv. Drug Deliv. Rev. 181, 114085 (2022).

Article  CAS  PubMed  Google Scholar 

Nguyen, D. H., Chong, A., Hong, Y. & Min, J. J. Bioengineering of bacteria for cancer immunotherapy. Nat. Commun. 14, 3553 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, S., Gravekamp, C., Bermudes, D. & Liu, K. Tumour-targeting bacteria engineered to fight cancer. Nat. Rev. Cancer 18, 727–743 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forbes, N. S. Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10, 785–794 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V. & Wargo, J. A. The impact of intratumoral and gastrointestinal microbiota on systemic cancer therapy. Trends Immunol. 39, 900–920 (2018).

Article  CAS  PubMed  Google Scholar 

Xie, Y. et al. Microbiota in tumors: from understanding to application. Adv. Sci. 9, e2200470 (2022).

Article  Google Scholar 

Fu, A. et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185, 1356–1372.e26 (2022).

Article  CAS  PubMed  Google Scholar 

Wang, M., Yu, F. & Li, P. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities. Front. Immunol. 14, 1269054 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Elsland, D. & Neefjes, J. Bacterial infections and cancer. EMBO Rep. 19, e46632 (2018).